Singapore markets open in 6 hours

Straits Times Index
3,292.69
+10.64(+0.32%)
S&P 500
5,093.86
+58.17(+1.16%)
Dow
38,334.25
+518.33(+1.37%)
Nasdaq
15,914.82
+257.00(+1.64%)
Bitcoin USD
59,071.36
-1,095.22(-1.82%)
CMC Crypto 200
1,223.41
-115.65(-8.64%)

ABT Jan 2025 80.000 put

OPR - OPR Delayed price. Currency in USD

Add to watchlist

0.9500

+0.0800

(+9.20%)

As of 11:54AM EDT. Market open.

Loading interactive chart…

Zacks
Is Trending Stock Abbott Laboratories (ABT) a Buy Now?
Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store.
Zacks
PBH vs. ABT: Which Stock Is the Better Value Option?
PBH vs. ABT: Which Stock Is the Better Value Option?
PR Newswire
Abbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the Knee
Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved the Esprit™ BTK Everolimus Eluting Resorbable Scaffold System (Esprit BTK System), a breakthrough innovation for people with chronic limb-threatening ischemia (CLTI) below-the-knee (BTK). The Esprit BTK System is designed to keep arteries open and deliver a drug (Everolimus) to support vessel healing prior to completely dissolving.